The Live Drop

Chernobyl Nuclear Disaster Veteran Dr. Sergei Belyakov Liquidates an Unseen Enemy

May 22, 2020 Sergei Belyakov Episode 38
The Live Drop
Chernobyl Nuclear Disaster Veteran Dr. Sergei Belyakov Liquidates an Unseen Enemy
Chapters
The Live Drop
Chernobyl Nuclear Disaster Veteran Dr. Sergei Belyakov Liquidates an Unseen Enemy
May 22, 2020 Episode 38
Sergei Belyakov

This episode isn’t so much about espionage or intelligence collection as it is an example of how understanding how what you don’t know can help shape your reality. How do you take precautions against an unseen and undefined threat - in this episode - to public health.  After getting his Phd in Chemistry, Sergei was called to duty by his reserve military unit for the clean-up at the Chernobyl nuclear reactor site in 1986.  As a ‘nuclear jumper’ he was in charge of 28 soldiers tasked with the dangerous duty of removing debris from the roof of the remaining structures. His 2011 book The Liquidator is a poignant memoir and scientific appraisal of these events.   Sergei discusses the vigilance and awareness necessary to manage an individual and public health threat: radiation or viral.  Sergei now runs his own nano-technology business based in Singapore which faces its unique challenges to contain the pandemic. With his 30 years in the chemical-pharma industry Sergei offers his recommendations. Episode 038

WNYC Public Radio Interview

Liquidators of Chernobyl - Youtube

Liquidator: The Chernobyl Story, Sergei Belyakov

Sergei Belyakov Biography:

Sergei A. BELYAKOV received his Ph.D. in organic/polymer chemistry (1984, USSR). After moving to the USA in 1992, he worked as a post-doctoral fellow with Prof. Alan R. Katritzky (University of Florida).

In 1998 Sergei moved to the pharmaceutical industry, joining Guilford Pharmaceuticals, a spin-off of Johns Hopkins University, where he developed novel drugs for CNS/metabolic diseases (collaboration with Amgen). In 2005-2006, with MGI Pharma, he led the team of scientists, which developed second generation (SG) Dacogen®, a promising anti-cancer drug.

From 2009, Sergei worked at AMRI Singapore, a CRO with expertise in the pre-clinical research, where he held a position of Assistant Director. He successfully guided multiple research teams totaling over 50 researchers in the areas of CNS, HIV and cancer diseases, collaborating with a range of the world-class pharma/biotech companies (Merck, GSK, Takeda, Sanofi etc.). In 2016, Sergei has started a new scientific research company, Theracross Technologies, co-establishing another start-up, Wintershine Health and Skincare, in 2018. Both companies focus on the development of novel delivery nano-systems for biomedicine, food industry, and personal care.

Sergei is an author and co-author of over 60 scientific papers and presentations, and of over 20 patents/patent applications, located in the areas of organic and medicinal chemistry and material science.

Sergei is a veteran-liquidator of Chernobyl NPP accident (1986); his accounts are gathered in his book “Liquidator: The Chernobyl Story”. He is the author of science fiction novels, and an avid basketball player and coach.

Show Notes

This episode isn’t so much about espionage or intelligence collection as it is an example of how understanding how what you don’t know can help shape your reality. How do you take precautions against an unseen and undefined threat - in this episode - to public health.  After getting his Phd in Chemistry, Sergei was called to duty by his reserve military unit for the clean-up at the Chernobyl nuclear reactor site in 1986.  As a ‘nuclear jumper’ he was in charge of 28 soldiers tasked with the dangerous duty of removing debris from the roof of the remaining structures. His 2011 book The Liquidator is a poignant memoir and scientific appraisal of these events.   Sergei discusses the vigilance and awareness necessary to manage an individual and public health threat: radiation or viral.  Sergei now runs his own nano-technology business based in Singapore which faces its unique challenges to contain the pandemic. With his 30 years in the chemical-pharma industry Sergei offers his recommendations. Episode 038

WNYC Public Radio Interview

Liquidators of Chernobyl - Youtube

Liquidator: The Chernobyl Story, Sergei Belyakov

Sergei Belyakov Biography:

Sergei A. BELYAKOV received his Ph.D. in organic/polymer chemistry (1984, USSR). After moving to the USA in 1992, he worked as a post-doctoral fellow with Prof. Alan R. Katritzky (University of Florida).

In 1998 Sergei moved to the pharmaceutical industry, joining Guilford Pharmaceuticals, a spin-off of Johns Hopkins University, where he developed novel drugs for CNS/metabolic diseases (collaboration with Amgen). In 2005-2006, with MGI Pharma, he led the team of scientists, which developed second generation (SG) Dacogen®, a promising anti-cancer drug.

From 2009, Sergei worked at AMRI Singapore, a CRO with expertise in the pre-clinical research, where he held a position of Assistant Director. He successfully guided multiple research teams totaling over 50 researchers in the areas of CNS, HIV and cancer diseases, collaborating with a range of the world-class pharma/biotech companies (Merck, GSK, Takeda, Sanofi etc.). In 2016, Sergei has started a new scientific research company, Theracross Technologies, co-establishing another start-up, Wintershine Health and Skincare, in 2018. Both companies focus on the development of novel delivery nano-systems for biomedicine, food industry, and personal care.

Sergei is an author and co-author of over 60 scientific papers and presentations, and of over 20 patents/patent applications, located in the areas of organic and medicinal chemistry and material science.

Sergei is a veteran-liquidator of Chernobyl NPP accident (1986); his accounts are gathered in his book “Liquidator: The Chernobyl Story”. He is the author of science fiction novels, and an avid basketball player and coach.